Variability in engraftment potential of different peripheral blood stem cell preparations given after cyclophosphamide, thiotepa, and carboplatin for stage II/III breast cancer.

被引：0
|
作者：
Elfenbein, G [1 ]
Perkins, J [1 ]
Janssen, W [1 ]
Fields, K [1 ]
机构：
[1] H LEE MOFFITT CANC CTR,DIV BONE MARROW TRANSPLANTAT,TAMPA,FL
来源：
EXPERIMENTAL HEMATOLOGY | 1996年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 48 条
  • [31] The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue
    Millar, BC
    Millar, JL
    Shepherd, V
    Blackwell, P
    Porter, H
    Cunningham, D
    Judson, I
    Treleaven, J
    Powles, RL
    Catovsky, D
    BONE MARROW TRANSPLANTATION, 1998, 22 (05) : 469 - 475
  • [32] The importance of CD34+/CD33− cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue
    BC Millar
    JL Millar
    V Shepherd
    P Blackwell
    H Porter
    D Cunningham
    I Judson
    J Treleaven
    RL Powles
    D Catovsky
    Bone Marrow Transplantation, 1998, 22 : 469 - 475
  • [33] Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast cancer with five to nine involved axillary lymph nodes
    Schwartzberg, LS
    Birch, R
    Tauer, KW
    Leff, R
    Greco, FA
    Hainsworth, J
    Raefsky, E
    McAneny, B
    Weaver, Z
    West, J
    Buckner, CD
    Weaver, CH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (02): : 136 - 142
  • [34] A retrospective study of high risk patients with stage II-III breast cancer undergoing high dose chemotherapy with peripheral blood stem cell (PBSC) rescue.
    Leppard, E
    BONE MARROW TRANSPLANTATION, 1998, 21 : S265 - S265
  • [35] Phase I-II study of 4 courses high-dose paclitaxel and carboplatin with peripheral blood stem cell (PBSC) for salvage treatment of ovarian cancer.
    Donato, M
    Mehra, R
    Gajewski, J
    Gershenson, D
    Bast, R
    Champlin, R
    BLOOD, 1996, 88 (10) : 3858 - 3858
  • [36] High dose cyclophosphamide (CY) carboplatin (Carbo) and autologous bone marrow transplantation (ABMT) peripheral blood stem cell transplantation (PBSCT) for metastatic breast cancer: An analysis of prognostic factors.
    Dasgupta, A
    Rajagopal, C
    Efird, J
    McAfee, S
    Meehan, K
    Mazumder, A
    Spitzer, T
    BLOOD, 1995, 86 (10) : 3757 - 3757
  • [37] Peripheral blood stem cell (PBSC) collection with cyclophosphamide (CY), epirubicin and recombinant human granulocyte-colony stimulating factor (rhG-CSF) in patients with breast and ovarian cancer.
    Demirer, T
    Ayli, M
    Demirer, A
    Ulusoy, V
    Fen, T
    Celik, Z
    Oymak, A
    Ozdel, O
    Ustael, N
    Ustun, T
    BLOOD, 2000, 96 (11) : 315B - 315B
  • [38] A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531
    Masters, Gregory A.
    Wang, Xiaofei
    Hodgson, Lydia
    Shea, Thomas
    Vokes, Everett
    Green, Mark
    LUNG CANCER, 2011, 74 (02) : 258 - 263
  • [39] Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer - Outpatient administration in community cancer centers
    Schwartzberg, LS
    Birch, R
    West, WH
    Tauer, KW
    Wittlin, F
    Leff, R
    Campos, L
    Rymer, W
    Carter, P
    Mangum, M
    Greco, FA
    Hainsworth, J
    Raefsky, E
    Blanco, R
    Buckner, CD
    Weaver, CH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (05): : 523 - 531
  • [40] DELAYED RECOVERY OF PERIPHERAL-BLOOD CELL NUMBERS AFTER ADJUVANT CYTO-TOXIC CHEMOTHERAPY FOR STAGE-II BREAST-CANCER
    GOODYEAR, MDE
    MACKAY, IR
    RUSSELL, IS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1981, 7 (01) : 37 - 40
12345